Scott Rocklage is a managing partner of a venture business known as 5AM Ventures. He rose to this position in 2004. Scott Rocklage first joined the firm as a venture partner in 2003, meaning within a year he had been promoted.
Scott Rocklage is a well-experienced individual in the healthcare department. He also has a well-grounded scientific experience. As a scientist, he has contributed immensely in the invention of drugs that have been approved by the Food and Drugs Agency (FDA). He has had three drugs approved.
These are Teslascan, Cubicin, and Omniscan. 5AM Ventures has its operation in the United States. Its offices are located in California, San Francisco, and Waltham. Dr. Scott Rocklage operates from the Waltham offices.
Scott Roklage had worked for numerous organizations before joining 5AM Ventures. Scott Rocklage was the CEO of Cubist Pharmaceuticals as well as Nycomed Salutar. Other companies he has held senior positions of leadership are, Ilypsa, Inc, Amersham Health and Novra Therapeutics among many more. His background in scientific studies has made him a guru in the healthcare sector, pharmaceuticals, and Venture Capital businesses.
Scott Rocklage education: Scott Rocklage holds a degree in Chemistry from the University of California. He is also a holder of a Ph.D. in chemistry from the MIT. In his doctorate studies, Scott Rocklage did some extensive research in the field of chemistry. He was conducting his research in the Richard R. Schrock laboratory.
Richard R. Schrock was a Nobel Prize winner in 2005 for his innovative works in the field of chemistry. As of today, Scott Rockage has about 30 patents to his name. Some as the sole founder and others as a co-founder.
Under the leadership of Scott Rocklage, the 5AM Ventures has been involved in operations that relate to life sciences. The role of 5AM Ventures is to support new startups in the healthcare sector to come up with solutions that are needed in the fields of medicine and science.
Some of the startups that are under 5AM are actively involved in coming up with new ways of diagnosing and treating some of the medical conditions that are yet to have a breakthrough such as cancer.
Learn more about Scott Rocklage: